blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3812365

EP3812365 - ROSMARINIC ACID DERIVATIVE OR SALT THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  26.03.2021
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  27.12.2019
Most recent event   Tooltip24.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Kao Corporation
14-10, Nihonbashi-Kayabacho 1-chome
Chuo-ku
Tokyo 103-8210 / JP
[2021/17]
Inventor(s)01 / TAKAMURA, Akihiro
c/o Kao Corporation Research Laboratories, 2606
Akabane, Ichikai-machi
Haga-gun, Tochigi 321-3497 / JP
02 / KITAMURA, Naoya
c/o Kao Corporation Research Laboratories, 2606
Akabane, Ichikai-machi
Haga-gun, Tochigi 321-3497 / JP
03 / YAMAMOTO, Naoki
c/o Kao Corporation Research Laboratories, 2606
Akabane, Ichikai-machi
Haga-gun, Tochigi 321-3497 / JP
04 / HASHIZUME, Kohjiro
c/o Kao Corporation Research Laboratories, 2606
Akabane, Ichikai-machi
Haga-gun, Tochigi 321-3497 / JP
 [2021/17]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2021/17]
Application number, filing date19821672.319.06.2019
[2021/17]
WO2019JP24322
Priority number, dateJP2018011736820.06.2018         Original published format: JP 2018117368
[2021/17]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019244937
Date:26.12.2019
Language:JA
[2019/52]
Type: A1 Application with search report 
No.:EP3812365
Date:28.04.2021
Language:EN
[2021/17]
Search report(s)International search report - published on:JP26.12.2019
(Supplementary) European search report - dispatched on:EP18.02.2022
ClassificationIPC:C07C69/732, A23L33/10, A61K31/216, A61P1/12, A61P13/10, A61P43/00, C07C69/736, C07K14/47
[2021/17]
CPC:
A23L33/105 (EP,US); C07C69/736 (US); A61K31/216 (EP);
A61P1/12 (EP); A61P13/10 (EP); C07C69/732 (EP);
C07C69/734 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/17]
TitleGerman:ROSMARINSÄUREDERIVAT ODER SALZ DAVON[2021/17]
English:ROSMARINIC ACID DERIVATIVE OR SALT THEREOF[2021/17]
French:DÉRIVÉ D'ACIDE ROSMARINIQUE OU SEL DE CELUI-CI[2021/17]
Entry into regional phase19.01.2021Translation filed 
19.01.2021National basic fee paid 
19.01.2021Search fee paid 
19.01.2021Designation fee(s) paid 
19.01.2021Examination fee paid 
Examination procedure19.01.2021Examination requested  [2021/17]
23.06.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
25.06.2021Renewal fee patent year 03
31.03.2022Renewal fee patent year 04
31.03.2023Renewal fee patent year 05
24.06.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO0156555  (GLAXO GROUP LTD [GB], et al) [Y] 4,7,10,13 * claims 1-3 *;
 [Y]WO03070233  (PHARMACIA CORP [US], et al) [Y] 3,6,9,12 * the whole document *;
 [XY]JP2005272362  (MEIJI SEIKA KAISHA) [X] 1-8,14-16 * paragraphs [0006] , [0007] , [0021] , [0022]; claims 1-8 * [Y] 3,4,6,7,9,10,12,13;
 [I]US2008031980  (RODRIGUEZ AL [US], et al) [I] 3,6,9,12 * paragraphs [0001] , [0011] , [0012] , [0033]; claims 1,2,18 *;
 [XI]WO2016122889  (KALEIDO BIOSCIENCES INC [US]) [X] 1-4,8 * page 199; claim 65; table 5 * * pages 75-76 * [I] 5-7;
 [I]JP2017052747  (KAO CORP) [I] 3,6,9,12 * paragraphs [0018] , [0044] , [0045]; claims 1,2 *;
 [XP]JP2018177738  (KAO CORP) [XP] 1-16 * the whole document *;
 [XP]JP2018177739  (KAO CORP) [XP] 1-16* paragraphs [0005] , [0011] , [0015] , [0017] , [0030] , [0031] , [0053] , [0055]; claims 2-6 *;
 [E]JP2020033272  (KAO CORP) [E] 1,3 * claims 1,2,4-7 *;
 [E]WO2020075764  (KAO CORP [JP]) [E] 1-16 * pages 11-12, paragraph 39 - page 14, paragraph 47; claims 1-3,5,7,8 * * page 11, paragraph 38 - page 14, paragraph 46 *;
 [XI]  - AL-QUDAH MAHMOUD A. ET AL, "Flavonoid and phenolic compounds from Salvia palaestina L. growing wild in Jordan and their antioxidant activities", PHYTOCHEMISTRY, Amsterdam , NL, vol. 99, doi:10.1016/j.phytochem.2014.01.001, ISSN 0031-9422, (20140301), pages 115 - 120, URL: https://www.sciencedirect.com/science/article/pii/S0031942214000041/pdfft?md5=95c8890eca0a0d5ecbcb76e76a280d49&pid=1-s2.0-S0031942214000041-main.pdf, XP055888888 [X] 1-4 * page 116, column l, paragraph 2; figure 1; compounds 3,7 * [I] 5-7

DOI:   http://dx.doi.org/10.1016/j.phytochem.2014.01.001
 [X]  - ZENG BIAO ET AL, "and Their Inhibitory Effects on [alpha] -Glucosidase and Vascular Endothelial Cells Injury", CHEMISTRY & BIODIVERSITY, CH, (20160501), vol. 13, no. 5, doi:10.1002/cbdv.201500187, ISSN 1612-1872, pages 596 - 601, XP055888867 [X] 1-4 * abstract *

DOI:   http://dx.doi.org/10.1002/cbdv.201500187
 [I]  - ALLAM SHADY ET AL, "Extracts from peppermint leaves, lemon balm leaves and in particular angelica roots mimic the pro-secretory action of the herbal preparation STW 5 in the human intestine", PHYTOMEDICINE, AMSTERDAM, NL, (20151101), vol. 22, no. 12, doi:10.1016/j.phymed.2015.08.008, ISSN 0944-7113, pages 1063 - 1070, XP055889298 [I] 4,7,10,13 * abstract * * pages 1065,-69 * * page 1070, column l, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/j.phymed.2015.08.008
 [I]  - MCKAY ET AL, "A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.)", PHYSIOTHERAPY RESEARCH, JOHN WILEY & SONS LTD. CHICHESTER, GB, (20060801), vol. 20, no. 8, doi:10.1002/PTR.1936, ISSN 0951-418X, pages 619 - 633, XP009145205 [I] 4,7,10,13 * the whole document *

DOI:   http://dx.doi.org/10.1002/ptr.1936
International search[A]JP2000072685  (NAGASE & CO LTD) [A] 1-22 * , *;
 [A]WO02062365  (MEIJI SEIKA KAISHA [JP], et al) [A] 1-22 * , *;
 [YA]JP2003521511  [Y] 4, 7, 10, 13, 19 , 22 * , * [A] 1-3, 5, 6, 8, 9, 11, 12, 14-18, 20, 21;
 [YA]JP2005526040  [Y] 3, 6, 9, 12, 18, 21 * , * [A] 1, 2, 4, 5, 7, 8, 10, 11, 13-17, 19, 20, 22;
 [XYA]JP2005272362  (MEIJI SEIKA KAISHA) [X] 1, 14-16 * , * [Y] 3, 4, 6, 7, 9, 10 , 12, 13, 18, 19 , 21, 22 [A] 2, 5, 8, 11, 17, 20;
 [A]JP2013216592  (KAO CORP) [A] 1-22* , *
by applicantJP2005139136
 KR20130087877
 JP2014024809
    - TIAN W., Am. J. Physiol. Renal. Physiol., (20040000), vol. 287, pages F17 - F24
    - NILIUS B., Physiol. Rev., (20070000), vol. 87, pages 165 - 217
    - GEVAERT T., J. Clin. Invest., (20070000), vol. 117, pages 3453 - 3462
    - NICOLAS CENAC et al., Gastroenterology, (20150000), vol. 149, pages 433 - 444
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.